Cite
HARVARD Citation
Freude, S. et al. (2016). Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β‐hydroxysteroid dehydrogenase‐1 (HSD1) inhibitor in humans: liver and adipose tissue 11β‐HSD1 inhibition after acute and multiple administrations over 2 weeks. Diabetes, obesity & metabolism. 18 (5), pp. 483-490. [Online].